Literature DB >> 25229298

Ventriculoperitoneal shunts for treating increased intracranial pressure in cryptococcal meningitis with or without ventriculomegaly.

Marcelo Corti1, Maria Priarone1, Ricardo Negroni2, Leonardo Gilardi3, Jimena Castrelo1, Alicia Irene Arechayala2, Fernando Messina2, Osvaldo Franze4.   

Abstract

INTRODUCTION: Cryptococcosis is an opportunistic mycosis, especially in patients that are human immunodeficiency virus (HIV)-positive, and frequently involves the central nervous system.
METHODS: We assessed the potential of ventriculoperitoneal shunting (VPS) in preventing mortality due to uncontrollable intracranial hypertension (ICH) in 15 patients with acquired immunodeficiency syndrome (AIDS)-related cryptococcal meningitis.
RESULTS: After 2 weeks of antifungal therapy consisting of amphotericin B deoxycholate with or without fluconazole, patients with persistent ICH underwent VPS, despite having persistent Cryptococcus neoformans infection. In 12 patients, the uncontrollable ICH was resolved by VPS.
CONCLUSIONS: Patients with cryptococcal meningoencephalitis who have ICH must be considered for VPS even with positive cerebrospinal fluid cultures.

Entities:  

Mesh:

Year:  2014        PMID: 25229298     DOI: 10.1590/0037-8682-0176-2013

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  8 in total

1.  Cryptococcal Meningitis: Diagnosis and Management Update.

Authors:  Mahsa Abassi; David R Boulware; Joshua Rhein
Journal:  Curr Trop Med Rep       Date:  2015-06-01

2.  [Early ventricle-atrium shunts for treating cryptococcal meningitis in children].

Authors:  Shi-Qi Guang; Fang He; Li-Wen Wu; Fei Yin; Jing Peng
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2018-10

3.  Virulence of Cryptococcus sp. Biofilms In Vitro and In Vivo using Galleria mellonella as an Alternative Model.

Authors:  Tatiane Benaducci; Janaina de C O Sardi; Natalia M S Lourencetti; Liliana Scorzoni; Fernanda P Gullo; Suélen A Rossi; Jaqueline B Derissi; Márcia C de Azevedo Prata; Ana M Fusco-Almeida; Maria J S Mendes-Giannini
Journal:  Front Microbiol       Date:  2016-03-09       Impact factor: 5.640

4.  Factors Associated With Ventriculoperitoneal Shunt Placement in Patients With Cryptococcal Meningitis.

Authors:  John W Baddley; George R Thompson; Kristen O Riley; Mary K Moore; Stephen A Moser; Peter G Pappas
Journal:  Open Forum Infect Dis       Date:  2019-05-20       Impact factor: 3.835

5.  Ventriculoperitoneal shunt is associated with increased cerebrospinal fluid protein level in HIV-infected cryptococcal meningitis patients.

Authors:  Ran Tao; Lijun Xu; Yongzheng Guo; Xiaoke Xu; Jiesheng Zheng; Biao Zhu
Journal:  BMC Infect Dis       Date:  2022-03-26       Impact factor: 3.090

6.  Therapeutic Lumbar Punctures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management?

Authors:  Enock Kagimu; Nicole Engen; Kenneth Ssebambulidde; John Kasibante; Tadeo K Kiiza; Edward Mpoza; Lillian Tugume; Edwin Nuwagira; Laura Nsangi; Darlisha A Williams; Kathy Huppler Hullsiek; David R Boulware; David B Meya; Joshua Rhein; Mahsa Abassi; Abdu K Musubire
Journal:  Open Forum Infect Dis       Date:  2022-08-17       Impact factor: 4.423

7.  Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis.

Authors:  Jia Liu; Zhuo-Lin Chen; Min Li; Chuan Chen; Huan Yi; Li Xu; Feng Tan; Fu-Hua Peng
Journal:  BMC Neurol       Date:  2018-05-01       Impact factor: 2.474

8.  Intraventricular cryptococcoma mimicking a neoplastic lesion in an immunocompetent patient with hydrocephalus: A case report.

Authors:  Xavier A Santander; Raquel Gutiérrez-González; Carlos Cotúa; Eva Tejerina; Gregorio-Boto Rodríguez
Journal:  Surg Neurol Int       Date:  2019-06-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.